Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3914)
All Articles published online
|
May 27, 2010 (publication date) through Jul 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Roderfeld M, Rath T, Lammert F, Dierkes C, Graf J, Roeb E. Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC. World J Hepatol 2010; 2(5): 175-179 [PMID: 21160992 DOI: 10.4254/wjh.v2.i5.175] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v2/i5/175.htm |
| Number | Citing Articles |
| 1 |
Klaudia Sztolsztener, Karolina Konstantynowicz-Nowicka, Anna Pędzińska-Betiuk, Adrian Chabowski. Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media. Cells 2023; 12(18): 2243 doi: 10.3390/cells12182243
|
| 2 |
Daria Capece, Mariafausta Fischietti, Daniela Verzella, Agata Gaggiano, Germana Cicciarelli, Alessandra Tessitore, Francesca Zazzeroni, Edoardo Alesse. The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/187204
|
| 3 |
Isao Okazaki, Takuji Noro, Nobuhiro Tsutsui, Eigoro Yamanouchi, Hajime Kuroda, Masayuki Nakano, Hiroaki Yokomori, Yutaka Inagaki. Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs). Cancers 2014; 6(3): 1220 doi: 10.3390/cancers6031220
|
| 4 |
Elke Roeb. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biology 2018; : 463 doi: 10.1016/j.matbio.2017.12.012
|
| 5 |
Maham Farshidpour, Monjur Ahmed, Shilpa Junna, Juanita L Merchant. Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review. World Journal of Gastrointestinal Oncology 2021; 13(1): 1-11 doi: 10.4251/wjgo.v13.i1.1
|
| 6 |
Jae-Min Cho, Kee-Young Kim, Sang-Deok Ji, Eun-Hee Kim. Protective Effect of Boiled and Freeze-dried Mature Silkworm Larval Powder Against Diethylnitrosamine-induced Hepatotoxicity in Mice. Journal of Cancer Prevention 2016; 21(3): 173 doi: 10.15430/JCP.2016.21.3.173
|
| 7 |
Hai Li, Hong You, Xu Fan, Jidong Jia. Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets. BMJ Open Gastroenterology 2016; 3(1): e000079 doi: 10.1136/bmjgast-2016-000079
|
| 8 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_182-1
|
| 9 |
Ni Wayan Armerinayanti, Samuel Widodo, Desak Putu Oki Lestari. Matrix Metalloproteinase 9 Expression by Immunohistochemistry in Intratumor Macrophages as Tumor-Associated Macrophage Marker of Papillary Thyroid Carcinoma. Biomedical and Pharmacology Journal 2022; 15(3): 1671 doi: 10.13005/bpj/2505
|
| 10 |
Usman Sabir, Hong‐mei Gu, Da‐Wei Zhang. Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis. Phytotherapy Research 2023; 37(11): 4932 doi: 10.1002/ptr.7959
|
| 11 |
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences 2023; 24(3): 2358 doi: 10.3390/ijms24032358
|
| 12 |
Le-Xing Yu, Yan Ling, Hong-Yang Wang. Role of nonresolving inflammation in hepatocellular carcinoma development and progression. npj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0048-z
|
| 13 |
Femke Heindryckx, Pär Gerwins. Targeting the tumor stroma in hepatocellular carcinoma. World Journal of Hepatology 2015; 7(2): 165-176 doi: 10.4254/wjh.v7.i2.165
|
| 14 |
Cuiyun Sun, Qian Wang, Hongxu Zhou, Shizhu Yu, Alain R. Simard, Chunsheng Kang, Yanyan Li, Yanling Kong, Tongling An, Yanjun Wen, Fudong Shi, Junwei Hao. Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo. Neuroscience Bulletin 2013; 29(1): 83 doi: 10.1007/s12264-012-1296-5
|
| 15 |
Antonio Gnoni, Daniele Santini, Mario Scartozzi, Antonio Russo, Antonella Licchetta, Vincenzo Palmieri, Luigi Lupo, Luca Faloppi, Giuseppe Palasciano, Vincenzo Memeo, Gioacchino Angarano, Oronzo Brunetti, Attilio Guarini, Salvatore Pisconti, Vito Lorusso, Nicola Silvestris. Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?. Expert Opinion on Therapeutic Targets 2015; 19(12): 1623 doi: 10.1517/14728222.2015.1071354
|
| 16 |
Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki, Naoki Matsumoto, Masahiro Ogawa, Shunichi Matsuoka, Seth J. Karp, Mitsuhiko Moriyama. Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives. International Journal of Molecular Sciences 2020; 21(14): 4906 doi: 10.3390/ijms21144906
|
| 17 |
Qiang-Bo Zhang, Qing-an Jia, Hong Wang, Chun-Xiao Hu, Dong Sun, Run-De Jiang, Zong-Li Zhang. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2883-z
|
| 18 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3351 doi: 10.1007/978-3-319-26956-6_182
|
| 19 |
Reham M. Dawood, Mai A. El-Meguid, Ghada Maher Salum, Mostafa K. El Awady. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020; 40(10): 472 doi: 10.1089/jir.2020.0059
|
| 20 |
Susanne N. Weber, Hermann E. Wasmuth. Liver fibrosis: from animal models to mapping of human risk variants. Best Practice & Research Clinical Gastroenterology 2010; 24(5): 635 doi: 10.1016/j.bpg.2010.07.013
|
| 21 |
Sandra Dios-Barbeito, Raúl González, Miryam Cadenas, Lisander F. García, Victor M. Victor, Francisco J. Padillo, Jordi Muntané. Impact of nitric oxide in liver cancer microenvironment. Nitric Oxide 2022; 128: 1 doi: 10.1016/j.niox.2022.07.006
|
| 22 |
Nadine Gehrke, Marcus A. Wörns, Amrit Mann, Yvonne Huber, Nadine Hoevelmeyer, Thomas Longerich, Ari Waisman, Peter R. Galle, Jörn M. Schattenberg. Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation. Oncotarget 2017; 8(34): 56095 doi: 10.18632/oncotarget.10893
|
| 23 |
Adnan Fayyad, Stefanie Lapp, Engy Risha, Vanessa M. Pfankuche, Karl Rohn, Yvonne Barthel, Dirk Schaudien, Wolfgang Baumgärtner, Christina Puff. Matrix metalloproteinases expression in spontaneous canine histiocytic sarcomas and its xenograft model. Veterinary Immunology and Immunopathology 2018; 198: 54 doi: 10.1016/j.vetimm.2018.03.002
|
| 24 |
Ersin Karatayli, Rabea A. Hall, Susanne N. Weber, Steven Dooley, Frank Lammert. Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(2): 298 doi: 10.1016/j.bbadis.2018.11.008
|
| 25 |
Susanne Nicole Weber, Annika Bohner, Dianne H. Dapito, Robert F. Schwabe, Frank Lammert, Matias A Avila. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver. PLOS ONE 2016; 11(7): e0158819 doi: 10.1371/journal.pone.0158819
|
| 26 |
Blanca Cucarull, Anna Tutusaus, Patricia Rider, Tania Hernáez-Alsina, Carlos Cuño, Pablo García de Frutos, Anna Colell, Montserrat Marí, Albert Morales. Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances. Cancers 2022; 14(3): 621 doi: 10.3390/cancers14030621
|
| 27 |
Florian Klemm, Johanna A. Joyce. Microenvironmental regulation of therapeutic response in cancer. Trends in Cell Biology 2015; 25(4): 198 doi: 10.1016/j.tcb.2014.11.006
|
| 28 |
Karuna Irungbam, Martin Roderfeld, Hannah Glimm, Felix Hempel, Franziska Schneider, Laura Hehr, Dieter Glebe, Yuri Churin, Gertrud Morlock, Imanuel Yüce, Elke Roeb. Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice. Laboratory Investigation 2020; 100(11): 1411 doi: 10.1038/s41374-020-0457-9
|
| 29 |
Daniel Zahner, Hannah Glimm, Tomomitsu Matono, Yuri Churin, Diran Herebian, Ertan Mayatepek, Kernt Köhler, Stefan Gattenlöhner, Anne Stinn, Annette Tschuschner, Martin Roderfeld, Elke Roeb. Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice. Oncotarget 2017; 8(32): 52560 doi: 10.18632/oncotarget.15003
|
| 30 |
Eleonora Timperi, Vincenzo Barnaba. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1263: 25 doi: 10.1007/978-3-030-44518-8_3
|
| 31 |
Shanshan Wan, Ning Kuo, Ilona Kryczek, Weiping Zou, Theodore H. Welling. Myeloid cells in hepatocellular carcinoma. Hepatology 2015; 62(4): 1304 doi: 10.1002/hep.27867
|
| 32 |
Ezhilarasan Devaraj, Anitha Roy, Geetha Royapuram Veeraragavan, Anitha Magesh, Aneymol Varikalam Sleeba, Lakshminarayanan Arivarasu, Brundha Marimuthu Parasuraman. β-Sitosterol attenuates carbon tetrachloride–induced oxidative stress and chronic liver injury in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2020; 393(6): 1067 doi: 10.1007/s00210-020-01810-8
|